Liu et al. [20] demonstrated that imatinib mesylate inhibits gastrointestinal stromal tumor cell proliferation through the Cdh1–Skp2–p27Kip1 pathway. The gene discussed is SKP2; the disease is gastrointestinal stromal tumor.